IQVIA Holdings Inc.
IndexS&P 500 P/E38.60 EPS (ttm)6.14 Insider Own0.78% Shs Outstand186.50M Perf Week3.36%
Market Cap43.87B Forward P/E21.95 EPS next Y10.81 Insider Trans0.00% Shs Float184.29M Perf Month14.15%
Income1.18B PEG3.31 EPS next Q2.76 Inst Own91.10% Short Float / Ratio1.08% / 2.36 Perf Quarter16.07%
Sales14.31B P/S3.07 EPS this Y246.20% Inst Trans0.41% Short Interest1.98M Perf Half Y1.21%
Book/sh28.67 P/B8.27 EPS next Y6.50% ROA4.80% Target Price254.85 Perf Year-6.79%
Cash/sh7.36 P/C32.23 EPS next 5Y11.65% ROE20.90% 52W Range165.75 - 256.62 Perf YTD15.76%
Dividend- P/FCF25.73 EPS past 5Y59.90% ROI6.60% 52W High-7.58% Beta1.39
Dividend %- Quick Ratio0.90 Sales past 5Y15.30% Gross Margin34.70% 52W Low43.10% ATR5.46
Employees85000 Current Ratio0.90 Sales Q/Q5.00% Oper. Margin13.20% RSI (14)67.98 Volatility2.12% 2.45%
OptionableYes Debt/Eq2.32 EPS Q/Q11.80% Profit Margin8.30% Rel Volume0.81 Prev Close240.65
ShortableYes LT Debt/Eq2.29 EarningsFeb 10 BMO Payout0.00% Avg Volume841.74K Price237.18
Recom1.60 SMA206.44% SMA5010.27% SMA20011.67% Volume680,691 Change-1.44%
Dec-06-22Initiated Cowen Outperform $251
Nov-17-22Downgrade Citigroup Buy → Neutral $275 → $245
Aug-25-22Initiated Credit Suisse Outperform $300
Jul-15-22Initiated SVB Leerink Outperform $256
May-24-22Initiated Guggenheim Buy $244
Apr-29-22Upgrade Piper Sandler Neutral → Overweight $231 → $255
Apr-25-22Downgrade Wells Fargo Overweight → Equal Weight $235
Aug-05-21Resumed Credit Suisse Outperform $272
Apr-16-21Upgrade Stephens Equal-Weight → Overweight $180 → $250
Mar-08-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight $218
Show Previous Ratings
Feb-03-23 10:00AM
Jan-31-23 09:59AM
Jan-30-23 05:25PM
Jan-25-23 05:35PM
04:15PM Loading…
Jan-20-23 08:25AM
Jan-18-23 12:26PM
Jan-11-23 08:44AM
Jan-06-23 07:00AM
Jan-05-23 02:08PM
Jan-03-23 11:05AM
07:34AM Loading…
Jan-02-23 07:34AM
Dec-28-22 08:30AM
Dec-20-22 09:45AM
Dec-08-22 02:13PM
Dec-02-22 11:31AM
Nov-25-22 11:31AM
Nov-14-22 07:19AM
Nov-11-22 11:47AM
Nov-10-22 11:00AM
Oct-27-22 02:49PM
Oct-26-22 03:25PM
Oct-24-22 04:15PM
02:12PM Loading…
Oct-20-22 02:12PM
Oct-19-22 10:01AM
Oct-18-22 01:01PM
Oct-12-22 07:22AM
Oct-11-22 02:45PM
Oct-10-22 11:40AM
Oct-07-22 09:01AM
Oct-06-22 08:15AM
Oct-04-22 11:46AM
Oct-03-22 04:15PM
Sep-30-22 03:07PM
Sep-28-22 10:00AM
Sep-23-22 05:12PM
Sep-22-22 08:05AM
Sep-20-22 04:31PM
Sep-19-22 10:06AM
Sep-16-22 05:59PM
Sep-07-22 08:15AM
Sep-06-22 10:36AM
Sep-05-22 08:35AM
Sep-02-22 03:16PM
Sep-01-22 04:15PM
Aug-29-22 07:14PM
Aug-23-22 10:00AM
Aug-15-22 07:30AM
Aug-12-22 11:56AM
Aug-11-22 02:51PM
Aug-10-22 02:18PM
Aug-09-22 03:19PM
Aug-08-22 08:06AM
Aug-04-22 11:50AM
Aug-03-22 11:32AM
Aug-02-22 02:40PM
Jul-27-22 03:32PM
Jul-26-22 11:14AM
Jul-22-22 06:30AM
Jul-21-22 05:30PM
Jul-18-22 01:36PM
Jul-14-22 10:00AM
Jul-07-22 04:15PM
Jul-06-22 07:30AM
Jul-05-22 02:16PM
Jun-30-22 05:35PM
Jun-28-22 11:40AM
Jun-27-22 06:15AM
Jun-24-22 12:50PM
Jun-15-22 07:57AM
Jun-07-22 08:00AM
Jun-01-22 08:00AM
May-31-22 02:28PM
May-30-22 09:40AM
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.